ArticleCardiovascular diabetology. Endocrinology reports2025
Differences in cardiovascular disease incidence according to changes in obesity status in young diabetic patients.
Article in Cardiovascular diabetology. Endocrinology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiac troponin and subclinical cardiovascular dysfunction in metabolic syndrome: a retrospective analysis based on two diagnostic definitions.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe relationship between obesity and cardiovascular disease (CVD) in obese patients with young-onset diabetes remains unclear. We investigated the incidence of CVD and the impact of changes in abdominal obesity status over time among patients with young-onset diabetes.
methodsWe defined young-onset diabetes as diagnosed before the age of 40. We analyzed data from 93,453 adults aged 20-39 with diabetes who underwent health screening between 2009 and 2011 and were followed up until 2021, using a customized Korean National Health Insurance Service database. Participants were categorized into four groups according to changes in abdominal obesity status: non-obese/non-obese, non-obese/abdominal obesity, abdominal obesity/non-obese, and persistent abdominal obesity. Hazard ratios (HRs) of the risk of CVD were calculated using Cox's proportional hazards model, adjusting for age, gender, smoking status, alcohol consumption, physical activity, and use of antihypertensives and lipid-lowering therapies.
resultsHR for all CVD events was 1.53 (95% CI, 1.42-1.65) in those with abdominal obesity compared to non-obese individuals based on the baseline abdominal obesity status. The group with persistent abdominal obesity during the follow-up period had a higher incidence of all CVD (HR, 1.59; 95% CI, 1.42-1.77), coronary heart disease (HR, 1.56; 95% CI, 1.35-1.80), stroke (HR, 1.57; 95% CI, 1.28-1.91), and heart failure (HR, 1.69; 95% CI, 1.29-2.22) compared to the non-obese group. In participants who transitioned from abdominal obesity to a non-obese status, the incidence of hemorrhagic stroke (HR, 1.40; 95% CI, 0.80-2.44) and heart failure (HR, 0.98; 95% CI, 0.62-1.55) was not significantly higher than the group maintaining a non-obese state.
conclusionsAbdominal obesity in young adults with diabetes is associated with a higher risk of CVD. Reducing waist circumference may mitigate the risk of hemorrhagic stroke and heart failure in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.